(Q84059837)

English

Short response duration even in responders to chemotherapy using conventional cytotoxic agents in recurrent or refractory clear cell carcinomas of the ovary

scientific article published on 03 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Short response duration even in responders to chemotherapy using conventional cytotoxic agents in recurrent or refractory clear cell carcinomas of the ovary (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1

object named as

Masashi Takano

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Tomoko Goto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Masafumi Kato

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Naoki Sasaki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Morikazu Miyamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kenichi Furuya

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

3 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

556-557

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

https://scigraph.springernature.com/pub.10.1007/s10147-012-0404-x

0 references

Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent ovarian clear cell carcinoma: complete remission after radiation in combination with hyperthermia; a case study and in vitro study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete response to radiation therapy in a patient with chemotherapy-resistant ovarian clear cell adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of recurrent ovarian cancer successfully treated with etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22552358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-012-0404-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552358%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84059837&oldid=1816299388"